#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Iron overload Myotonia Pulmonary fibrosis B-cell lymphoma recurrent Retinopathy of prematurity Bronchopulmonary aspergillosis Aicardi-Goutieres syndrome Thromboangiitis obliterans Congenital growth hormone deficiency Follicular lymphoma stage I Gestational trophoblastic tumour Restless legs syndrome Hidradenitis Paraganglion neoplasm Antiphospholipid antibodies More trials…

    Learn about Rare Diseases

    Retinoblastoma – Diagnostics Methylmalonic acidaemia – Life with Disease Haemophilia B without inhibitors – Diagnostics Hairy cell leukaemia recurrent – Trials in Disease Nodal marginal zone B-cell lymphoma – Basic Information X-linked lymphoproliferative syndrome – Diagnostics Pleomorphic leiomyosarcoma – Life with Disease Osteosarcoma metastatic – Trials in Disease SAPHO syndrome – Trials in Disease Thrombotic thrombocytopenic purpura – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Midazolam Hydrochloride Bempikibart Abemaciclib VG801-1 Soticlestat OMTX705 Gentamicin Sulfate RNK001 BMS-986365 Bromocriptine Bicalutamide Elexacaftor Citalopram Hydrochloride Enfuvirtide Aclidinium Bromide Copanlisib Dihydrochloride Alitretinoin Verapamil Divarasib Iloprost Trometamol More therapies…

    Learn about Your Condition

    Migraine without aura Hypertriglyceridaemia Retroperitoneal fibrosis Bladder cancer stage II Breast cancer female Transplantation complication Duchenne muscular dystrophy Multiple sclerosis relapse Adenovirus infection Vitamin D deficiency Pneumonia Hypotransferrinaemia Soft tissue sarcoma Oxygen therapy Pancreatitis acute More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study on Using Gentamicin and Clindamycin to Prevent Abscesses After Surgery for Complicated Appendicitis in Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Appendicitis perforated
    • Complicated appendicitis
    • Peritoneal abscess
    Investigated Drugs:
    • Gentamicin
    • Clindamycin
    The Netherlands

  • Study on Human Albumin Solution and Ringer Lactate for Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Metastases to peritoneum
    Investigated Drugs:
    • Human Albumin Solution
    • Mannitol
    France

  • Study on the Safety of Rotigotine for Patients with Autosomal Dominant Polycystic Kidney Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Congenital cystic kidney disease
    Investigated Drugs:
    • Rotigotine
    France

  • Study of Dostarlimab for Patients with Untreated Stage III Resectable Colon Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Dostarlimab
    Belgium

  • Study on Regorafenib with Cyclophosphamide, Capecitabine, and Aspirin for Patients with Metastatic Colorectal Cancer

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Anhydrous Cyclophosphamide
    • D,L-Lysine Acetylsalicylate
    • Regorafenib
    France

  • Study Comparing Norfloxacin and Conventional Antibiotics for Hospitalized Patients with Decompensated Cirrhosis and Bacterial Infections

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Norfloxacin
    Spain
Previous Page
1 … 15 16 17 18 19 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!